Compromised Dynamic Cerebral Autoregulation in Patients with Restless Legs Syndrome
Yanan Zhang,Qianqian Chen,Qingqing Sun,Mingyang Tang,Yi Yang,Zhen-Ni Guo,Zan Wang
DOI: https://doi.org/10.2147/nss.s448579
2024-04-30
Nature and Science of Sleep
Abstract:Yanan Zhang, 1 Qianqian Chen, 1 Qingqing Sun, 1 Mingyang Tang, 1 Yi Yang, 1, 2 Zhen-Ni Guo, 1, 2 Zan Wang 1, 2 1 Sleep Center, Department of Neurology, The First Hospital of Jilin University, Chang Chun, People's Republic of China; 2 Stroke Center, Department of Neurology, The First Hospital of Jilin University, Chang Chun, People's Republic of China Correspondence: Zhen-Ni Guo, Stroke Center, Department of Neurology, The First Hospital of Jilin University, Xinmin Street 1&num, Chang Chun, 130021, People's Republic of China, Tel +86-431-88782378, Email Zan Wang, Sleep Center, Department of Neurology, The First Hospital of Jilin University, Xinmin Street 1&num, Chang Chun, 130021, People's Republic of China, Tel +86-431-88782378, Email Background: Restless legs syndrome (RLS) is a prevalent sensorimotor nervous system disorder in patients accompanied with insomnia, blood pressure fluctuation, and sympathetic dysfunction. These symptoms may disrupt cerebral hemodynamics. Dynamic cerebral autoregulation (dCA) describes the temporary response of cerebrovascular system to abrupt fluctuations in blood pressure, which keep cerebral blood flow stable and serve as a marker of cerebrovascular system ability. Objective: This research aimed to assess dCA in RLS patients. Methods: In this study, RLS patients were recruited and subsequently classified into four groups (mild, moderate, severe, and very severe) based on the International RLS Rating Scale (IRLS). Healthy controls matched for age and sex were enrolled. All participants were evaluated dCA by assessing phase difference (PD). A portion of patients with RLS was reassessed for dCA after one month of medication therapy (pramipexole [0.125 mg/day] and gabapentin [300 mg/day]). Results: There were altogether 120 patients with RLS and 30 controls completed the polysomnography and dCA assessment. PD was lower in the moderate, severe, and very severe RLS groups than that in the controls and mild RLS groups. Periodic limb movement index (PLMI), arousal index, and IRLS all showed a linear correlation with PD in RLS patients. Additionally, PD increased in RLS patients after therapy. Conclusion: The dCA was compromised in moderate, severe, and very severe RLS patients and was negatively correlated with the IRLS, arousal index, and PLMI. After 1 month of therapy, dCA improved in RLS patients. Keywords: restless legs syndrome, dynamic cerebral autoregulation, autonomic nerve dysfunction, dopaminergic Restless legs syndrome (RLS) is a sensorimotor nervous system disorder marked by extreme discomfort in both lower limbs, with irresistible movement impulses in the evening or when it is quiet, and continuous movement could partially or completely alleviate this impulse. 1 It may cause insomnia, fatigue, blood pressure fluctuation, and sympathetic dysfunction. 2 A series of trends appeared suggesting that the risk variables for stroke and RLS interacted. 3 Several studies have found that people with RLS who had periodic limb movements in sleep (PLMS) have cerebral hemodynamic disturbances. 3,4 Byun et al used near-infrared spectroscopy to find that there were no changes in the low-frequency oscillations between oxyhemoglobin concentration and deoxyhemoglobin concentration during the different sleep stages, which shows that RLS patients with PLMS had cerebral hemodynamic disturbances, and sympathetic hyperactivity has been suggested as the underlying mechanism. 4 RLS patients are prone to erectile dysfunction, and the risk increases with a higher frequency of RLS symptoms. 5,6 Shneyder et al found that more autonomic complaints were present in RLS patients, mainly in sialorrhea, heat intolerance, dizziness on standing, early abdominal fullness, and constipation. 7 Furthermore, patients with RLS have been shown to have decreased nitric oxide (NO) levels, elevated nitrite oxide synthase expression, compromised vascular endothelial function, and increased arterial stiffness, 8–11 which may disturb cerebral hemodynamics and increase the risk of cerebrovascular disease. 12 However, it is not easy to determine the underlying functional alterations of cerebrovascular disease. Dynamic cerebral autoregulation (dCA), is the brain's natural ability to sustain cerebral blood flow under conditions of rapid and significant variations in arterial blood pressure. It is defined as the instantaneous rate of change of cerebral blood flow to cerebral perfusion pressure. 13 Among the evaluation parameters were phase difference (the primary metric, indicates the phase ch -Abstract Truncated-
neurosciences,clinical neurology